Early treatment with vidofludimus calcium may lead to less long-term disability in people with progressive forms of MS, data ...
The Committee for Medicinal Products for Human Use (CHMP) – part of the European Medicines Agency – has recommended a new treatment for multiple sclerosis (MS). The health regulator has has deemed ...
The best treatment for multiple sclerosis (MS) might be antivirals that target the Epstein-Barr virus. Pharmaceutical companies are now being called on to develop such drugs after researchers studied ...
A therapeutic approach pioneered in Mainz for the treatment of multiple sclerosis (MS) is taking an important step toward clinical application. The team led by Professor Claire Jacob at Johannes ...
People with multiple sclerosis (MS) who are treated with rituximab have an increased risk of developing inflammatory bowel ...
NHS England (NHSE) has announced that the first drug designed to improve walking in adults with multiple sclerosis (MS) would now be routinely available on the NHS. Fampridine (Fampyra, Alkermes) acts ...